An outline of India's Medical Devices market, along with practical tips on Market Entry for Startups and SME's on navigating the complexities. For more details connect at https://ontogenix.com
Narayana hrudayala heart hospital Business StrategyAshis Sarangi
The slide include how Devi Shetty implemented his business strategy in order to position his trust among all by giving below cost quality care and in order to compensate the investment, he indirectly targeted rural areas in the form of insurance scheme and also the scheme helped him in planing to expand his business for long time sustainability.
STRATEGIC MANAGEMENT OF NARAYANA HRUDRALAYASheetal Singh
This presentation contains strategic management research of Narayana hrudralaya which include Internal analysis, External analysis and Financial analysis of NH.
This is a report about Indian Health care industry and How different sectors like Hospitals, Pharmacy and Diagnostics industry are growing. What are the new government policies that are implemented for Health care sector in India.
Narayana hrudayala heart hospital Business StrategyAshis Sarangi
The slide include how Devi Shetty implemented his business strategy in order to position his trust among all by giving below cost quality care and in order to compensate the investment, he indirectly targeted rural areas in the form of insurance scheme and also the scheme helped him in planing to expand his business for long time sustainability.
STRATEGIC MANAGEMENT OF NARAYANA HRUDRALAYASheetal Singh
This presentation contains strategic management research of Narayana hrudralaya which include Internal analysis, External analysis and Financial analysis of NH.
This is a report about Indian Health care industry and How different sectors like Hospitals, Pharmacy and Diagnostics industry are growing. What are the new government policies that are implemented for Health care sector in India.
This Power Point Presentation is about the health care industry its opportunities in growing market and the company profile and swot analysis of Apollo Hospitals
A comprehensive analysis of Apollo Hospitals [Biswadeep Ghosh Hazra and Team]...Biswadeep Ghosh Hazra
The report covers the essential strategic aspects of Apollo Hospitals which are enumerated below-
1 Executive Summary
2 Industry Overview
2.1 Nature and Size of the Industry
2.2 Key Growth drivers for the industry
2.3 Identification of Critical Success Factors (CSF)
2.4 Market Analysis based on CSFs
2.5 Industry Benchmarks
2.6 PESTEL Analysis
2.7 Porter’s Five Forces Analysis
2.8 Strategic Group Mapping
2.9 Competitive Landscape
2.10 Market Segmentation
2.11 Buying Criteria Analysis of the Industry
2.12 Key trends and future developments
3 Company Overview
3.1 Company background
3.2 Timeline with key milestones and their strategic impact
3.3 Vision, Mission, Goals, and Strategic Themes
3.4 Key Product and Service Portfolio
3.5 Core Competencies of the firm
3.6 Business Model of the organization
3.7 3rd Generation Balanced Scorecard (Amalgamation of 1st Generation BSC and Activity System Map)
3.8 SWOT Analysis
3.9 Competitor Analysis (identify competitors)
3.9.1 Based on Critical Success factors
3.9.2 Based on Financial indicators
4 Future Growth Strategy for the organization
4.1 Portfolio Analysis
4.1.1 Based on BCG Matrix
4.2 Company’s Strategic Roadmap for future
4.3 Product Market Investment Strategy
4.4 Re-imagining the Organization with
the transformed business model or Use-case based on SMAC and IOE
This Power Point Presentation is about the health care industry its opportunities in growing market and the company profile and swot analysis of Apollo Hospitals
A comprehensive analysis of Apollo Hospitals [Biswadeep Ghosh Hazra and Team]...Biswadeep Ghosh Hazra
The report covers the essential strategic aspects of Apollo Hospitals which are enumerated below-
1 Executive Summary
2 Industry Overview
2.1 Nature and Size of the Industry
2.2 Key Growth drivers for the industry
2.3 Identification of Critical Success Factors (CSF)
2.4 Market Analysis based on CSFs
2.5 Industry Benchmarks
2.6 PESTEL Analysis
2.7 Porter’s Five Forces Analysis
2.8 Strategic Group Mapping
2.9 Competitive Landscape
2.10 Market Segmentation
2.11 Buying Criteria Analysis of the Industry
2.12 Key trends and future developments
3 Company Overview
3.1 Company background
3.2 Timeline with key milestones and their strategic impact
3.3 Vision, Mission, Goals, and Strategic Themes
3.4 Key Product and Service Portfolio
3.5 Core Competencies of the firm
3.6 Business Model of the organization
3.7 3rd Generation Balanced Scorecard (Amalgamation of 1st Generation BSC and Activity System Map)
3.8 SWOT Analysis
3.9 Competitor Analysis (identify competitors)
3.9.1 Based on Critical Success factors
3.9.2 Based on Financial indicators
4 Future Growth Strategy for the organization
4.1 Portfolio Analysis
4.1.1 Based on BCG Matrix
4.2 Company’s Strategic Roadmap for future
4.3 Product Market Investment Strategy
4.4 Re-imagining the Organization with
the transformed business model or Use-case based on SMAC and IOE
Innovation in medical device and diagnostic industry at India Leadership Conc...Indian Affairs
Conceptualized& instituted in the year by India’s most respected journalist Satya Brahma, India Leadership Conclave Awards are are meant to highlight & celebrate those individuals & companies who’ve ascended to the top of their business against all odds. Currently celebrating its 9th successful annual editions, iconic figures such as Ratata Tata, MukeshAmbani, Naresh Goyal, Narayan Murthy, Shiv Nadar,SudhaMurthy,Priyanka Chopra, Manish Malhotra, Neeta Lulla, Late Yash Chopra, Govinda, Rani Mukerjee, Sushimita Sen, Karishma Kapoor are some of its proud recipients. Being India’s most iconic leadership awards having a tremendous impact on the credibility of the Group, India Leadership Conclave jury takes every steps to ensure fair, credible & independent selection process,.The nomination categories, eligibility criteria, selection process & evaluation criteria constitute the core areas of research. Public voting constitutes its biggest parameters. Physical interviews by Network 7 Media Group Journalists on ground on each nominee are conducted followed by Jury’s strong analytical verdict. The set of awards developed by the Board Members of the Network 7 Media Group is to propel the talent engine & encourage, motivate the innovative entrepreneurs. These leadership awards are aimed at empowering the leaders who think differently.This recognition voted by the people of india& subsequent by Jury Board reflect the Winner’s remarkable achievement & accomplishments as a leader of substance driven by passion, initiative & commitment to deliver excellence. India Leadership Conclave Awards are special as we don’t follow any traditional guidelines, defy conventions & crown winners based on innovations, merit & competence. Our decision is based on number of factors which are transparent, robust & driven by extensive research.
Introduction to investing in the Indian stock market.
Factors to consider when choosing a share to buy.
Overview of the Indian economy in 2024.
Top sectors expected to perform well in 2024.
Analysis of the current market trends and opportunities.
Research on the best-performing companies in 2024.
Evaluation of the financial health and growth potential of selected shares.
Expert recommendations on the best share to buy in 2024.
Risk assessment and mitigation strategies for investing in the chosen share.
The Indian healthcare industry has progressed at an impressive pace over the past few years. The private sector has emerged as a vibrant force in the industry, accounting for almost 74 per cent of the country’s total healthcare expenditure.
The Indian healthcare revenues stood at US$ 68.4 billion in 2011 and is expected to reach US$ 158.2 billion by 2017. Of the total healthcare revenues in the country, hospitals account for 71 per cent, pharmaceuticals for 13 per cent and medical equipment and supplies for 9 per cent.
India offers both a huge patient pool, favourable regulatory environment and cost advantage for conducting clinical trials. The low cost of medical services has resulted in a rise in the country’s medical tourism, attracting patients from across the world.
The Government of India has created the National Health Mission (NHM) for providing effective healthcare to both urban and rural population.
Opportunity analysis of life science tools market in India - A srinivas sash...Srinivas Sashidhar
An analysis of the life science tools market in India and the market opportunity.
Please note this is a proprietary research on my views in a series of srinivas sashidhar's healthcare instinct. Your views and comments are welcome.
I am also open to individual assignments on market consulting in healthcare related markets.
You can follow my blog at https://kchsashi.blogspot.com/
Our analysis regarding the evolution of what we believe is the development of the Healthcare Cloud. We discuss the siloed nature of HCIT in terms of legacy and cloud and discuss how we believe entities need to shift from point to platform solutions over time. We also lay out the fundamental underpinnings of what makes a compelling digital healthcare investment.
The Foundations of Success in Population Health ManagementHealth Catalyst
From hospital systems to large employers, organizations are increasingly taking on financial risk for the health of populations. Drivers of this trend include the update to the MSSP model, the recent CMS Primary Cares Initiative announcement, the increasing prevalence of the Medicare Advantage model, innovative partnerships in the self-insured employer space, and the proliferation of Medicaid ACOs. Yet while market pressures push organizations toward population risk, they don't necessarily help them succeed: most organizations are struggling to attain or sustain the dual imperatives of high-quality care and cost containment. A primary reason? Short-sighted and tactical approaches that don't provide the flexible data infrastructure and tools to adapt to emerging trends in population health—or to support short-term contractual requirements while building toward long-term success.
View this launch webinar to learn about Health Catalyst’s Population Health Foundations solution, a data and analytics-first starter set aimed at optimizing performance in value-based risk arrangements and providing the data ecosystem that will flex and adapt to complex needs of risk-bearing organizations. Solution services ensure that the strategic value of data is maximized to improve performance in risk contracts—and provide side-by-side subject matter expert partnership for establishing short- and long-term goals for population health management (PHM).
Built on Health Catalyst’s foundational technology and supported by the nationwide experience and perspective of its experts, the Population Health Foundations solution helps organizations leverage multiple data sources to understand their patient populations and create meaningful views of financial and clinical quality performance. As a starter set that organizations can build on based on their needs, the solution is designed to compensate for the known limitations of “black box” population health applications that fail to reveal the “why” of analytic insights and exacerbate the challenges of transforming quality, cost, and care. The Population Health Foundations solution delivers the essential analytic tools needed for success under value-based risk arrangements.
In these slides you can expect to:
- Review recent changes to the field of value-based care, and reactions and insights from the market
- Discover how the Population Health Foundations solution can act as a comprehensive, data-first analytics solution to support your population stratification and monitoring needs
- Understand how this solution functions as a foundational starter set for value-based care success, enabling clients to leverage all their data and other relevant population health tools
Presentation by Noel Harvey, VP R&D, and Al Lauritano, Head of Strategic Technology Partnerships, Becton Dickinson, on January 19, 2015 for mHealth Israel meetup.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
2. Authors Bio
linkedin.com/in/mbala5
Balasubramaniam M
A healthcare leader with deep domain knowledge
and understanding of the APAC Healthcare
Industry, backed by more than 2 decades of
managing large & medium organizations with
complete P&L responsibility. Served in senior
management roles in India and Singapore.
Shikharesh Das
Senior executive specialized in execution of
commercialization & market entry strategy, in a mix of
MNC & SME experience in regional and global roles.
Strong track record in business development, sales,
and marketing. Highly connected in start-up
ecosystem.
linkedin.com/in/shikharesh/
2
3. Agenda
1. Indian Healthcare Landscape
2. MedTech Opportunity
3. Healthcare Delivery
4. Distribution Models
5. Start-up : Tips for Market Entry
3
Image copyright attributes:
https://commons.wikimedia.org/wiki/File:Taj-
Mahal.jpg
https://en.wikipedia.org/wiki/File:Wockhardt_Hospi
tal_Bangalore.jpeg
4. Country Overview
Growing Population : India’s population is set to
touch 1.45 billion by 2028.
Life Expectancy : Life expectancy in India is
expected to increase to 70 years by 2025
Changing Preferences: Increasing lifestyle
diseases driving towards preventive healthcare,
Growing Middle Class: A rapidly growing
middle class has contributed to the growth of
private players
Policy Support & Incentives : 100% FDI
allowed in Greenfield & Brownfield projects,
India Healthcare Landscape Overview
Medtech Indices
Shifting Disease Burden: Non-Communicable
Diseases account for 60% of all deaths in India
Health Insurance: Approx. 40% of Indians
have health insurance cover
Rise in Medical Tourism: experiencing a 22-
25% growth. It contributes over $2 BN to the
healthcare market in India.
Nascent MedTech industry: Imports more
than 90% of sophisticated devices, domestic
industry has a huge scope for R&D capacity
Infrastructural Development: Four medical
devices parks active in India
4
5. Macro Health Economic Data* – India
5
Govt Healthcare Spend
US$170 BN, CAGR ~ 30%
Hospital Spend
US$120 BN
Med Tech Spend
US$11 BN
* Est in 2019
• Reach : Disruptive models emerging to scale & meet the unmet demand
• Manufacturing: Value products, D & D through Frugal Innovation & leverage sourcing efficiency
• Technology: Center of Excellence on core technology. X-ray Tubes, Flat Panel Detectors, Sensors
• Equipment as Service: Combine efficiency in Sourcing, extending Life cycle & Asset management,
6. Is Med-Tech the next wave?
6
• Estd. lead in early 2000’s
• US$ 6.0 BN in ‘05 to US$
55 BN in ‘20
• FDI US$ 11B
• Import < 15%
• FDI US$ 3.0 BN
• Growth in smaller cities
• NHPS – 500 MN new
patients
• Currently 85% imported
• Cost Vs Quality balance
• Frugal innovation is key
• Opportunity to replace
imports
Pharma
Set early pace
Hospitals
Following pharma’s pace
Med. Tech
Next growth Engine?
FDI = Foreign Direct Investment NHPS = National Health Protection Scheme
7. ▪ Med Devices in Govt. Strategic focus
▪ Increasing demand > supported by
Govt. investments
▪ Focus on import substitute & export
to emerging markets
▪ Medical Devices Bill : Quality &
Regulatory focus
▪ Destination India : Manufacturing
base to attract companies currently
sourcing from other parts of Asia
Med Tech Innovation : Next Big wave &
Disruption opportunity
India Med-Tech Opportunity : Favourable factors
7
The copyright belong to publishers
8. 6th Largest Global Market
Expected to rank in the top 3 by 2025
India Med-Tech Opportunity – Market Size
Segment Total Sales USD
MN (Est 2020)
Imports %
Disposables &
Consumables
3,200 35%
Equipment's 6,000 85%
Implants 750 80%
In Vitro Reagents 880 75%
Total 10,830 75%
Key Summary
• Market is expected to grow to $20B by 2025
with CAGR @15%
• MedTech imports constitute about 85%.
“Make in India” initiative to improve self-
sufficiency in Med-Tech
• Innovation ecosystem is fast evolving and
vibrant > local startups co-creating products
• Government,Academic Research, Incubators,
VC firms providing funding support.
• Vendor ecosystem developed by MNC’s
provide good starting point
• Type of product determines optimum target
segment and sector (Govt or Private)
8
0% 20% 40% 60% 80% 100%
Spend
Beds
Govt Private
https://www.statista.com/statistics/1128673/india-number-of-public-and-private-hospital-beds-estimated/
9. India Healthcare delivery
Private has larger share of market
Tertiary Care
Intermediate care
Villages
Primary Care
Govt 40%
Core hospitals in
key cities
Distributed clinics
Limited Presence
Private 60%
70% of
population
MedTech net value: 30% in
Tertiary Hospital investments.
Premium /High performance
market
MedTech net value: 50% in
Intermediate care
investments. Opportunity for
Value / affordable solutions
Driver
Shortage of skilled manpower.
<20% of resources deployed.
Increase access, remote solutions
using innovative technology / AI
Tier 1
Cities
Tier 2 & 3
Cities
9
Tier definition: https://aspiringyouths.com/general-knowledge/tier-1-tier-2-indian-cities/
10. Tertiary Care
Drivers
• Patient Care / Outcomes
• Clinical efficacy / Staying ahead
• High throughput / Productivity
• Seamless Connectivity within
Group Hospitals
• Lifetime ownership costs
important
10
AIIMS New Delhi
Care Hospital Hyderabad
Apollo Hospital, Delhi
11. Primary Healthcare
Key considerations:
• Access
• Affordability
• Quality of care
• Remote solutions
• Wearable / AI
11
Image credit: https://pixnio.com/science/medical-science/doctor-inspects-a-child
12. Distribution Overview
N
W
S
E
• Strong Regional distributors exist with
local relationships. Few National
distributors exist
• Hybrid distribution models are popular
• Medtech devices / Consumables leverage
‘stockist’ models
• Digital channels / e-commerce platforms
are now growing
• Govt purchases are higher in Capital
region in the North
• Net prices are generally higher in the
South & West
12
The geographicaldivisionsare shown just to illustratehow companiesusuallysplittheir regions
https://commons.wikimedia.org/wiki/File:India-map-en.svg
13. Distribution Models
Hybrid model
• Most popular
• Local distributor provides customer facing activity. Company bills & pay
dealer commission.
• Parent company undertakes certain financials and logistics risks
Direct Distribution
model
• Upcoming model for certain products
• Large Distributors operate on Stock & Sell model with min. annual commitment
• Auto replenishment of stock on reaching inventory threshold
• Distributors focus on last mile delivery, payments & relationships
Electronic
Marketplace
• Gaining popularity
• Disruption in Consumables / low value equipment
• Replaces consignment model for inventory. Manages customer inventory
• Payment solutions need to evolve for better adoption
1
3
2
13
14. Government support for MedTech Industry
https://www.investind
ia.gov.in/setting-up-
business-in-india
14
Key Observations on Govt. Support :
1. Startups can choose any of the entry options depending on the long term strategic plan.
2. Govt. Support like Production linked incentive, Preferential market access, Price preference in
public tenders are available for manufacturing companies n India
3. Access to MedTech parks and incentives given to manufacturers are available to Foreign
companies
15. India Medical Device Registration Pathway
15
Online application
Click on link
Received by Nodal
Officer
Forwarded to reviewing
officer
Forwarded to Dy
Director Admin
Approval granted online
Forwarded to
Licensing Authority
Queries on
deficiency
Learn about CDSCO
Download CDSCO Manual
See Classification of Devices
CDSCO = India’s FDA
https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/GCT_PDFs/Approval_process_flowchart_GCT_Online.pdf
Note: timeline for approval varies
based on novelty of device
16. Challenges for Healthcare Start-ups & Mitigation plan
Sl no Description Solution
1 Revamped Regulatory
Framework: MDR 2017 : Backed by
government and other industry-
regulatory apex bodies
Obtain CE mark or FDA First.
Then apply for India CDSCO
registration.
2 Infrastructure support required for
adoption
Understand local workflow and
legacy system
3 ‘Me too’ products offerings Will not take off – avoid market entry
4 Absence of National Distributors Go by region, focus on one region
for entry & expand
5 Many local players Identify and focus on niche
segment. Leverage local partners
16
17. Key takeaways
• Look for niche underserved sector with
a need
• Navigate regulatory: Get CE or FDA
first > then apply for local license
• Collaborate with strong local partner
• Be ready for volume game
• Access to 6th largest market
• Outstanding clinical data source
• Inexpensive market access
• Strong local IP protection
• Easy legal access by Arbitration route
Recommended steps for entry
Benefits for Entrant
• Large growing patient population
• Increased spending power
• Easy adoption to private sector
• Lower operational costs
• Innovative business models: Revenue
share, Equipment as a service
• Bring products tailored to India needs.
• Leverage India’s clinical spread
• Deliver quality at moderate prices.
Upfront cost differentiation is critical.
• Provide prompt & efficient service
What India offers Key considerations
17
18. Strategy &
GTM models
Distributor Search
& management
Market Research
& pricing
Email: info@ontogenix.com
Web: https://www.ontogenix.com
This is a document of Ontogenix Pte Ltd Singapore and are meant only for personal use.
It should not be shared, forwarded or reproduced without written consent from company. 18